Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Gabelli 18th Annual Sports & Media Symposium Agenda Released

May 14, 2026

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

May 14, 2026

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

May 14, 2026

Jackery Brings the Power and Savings to Memorial Day Weekend

May 14, 2026

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

May 14, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Dholakia Lab Grown Diamond Raises ₹800+ Crore to Lead India’s Fast-Growing LGD Segment
Press Release

Dholakia Lab Grown Diamond Raises ₹800+ Crore to Lead India’s Fast-Growing LGD Segment

By News RoomMay 8, 20266 Mins Read
Dholakia Lab Grown Diamond Raises ₹800+ Crore to Lead India’s Fast-Growing LGD Segment
Share
Facebook Twitter LinkedIn Pinterest Email

MUMBAI, India, May 08, 2026 (GLOBE NEWSWIRE) — Dholakia Lab Grown Diamond Private Limited (DLGD) today announced it has raised over ₹800 crore led by Abakkus PE, alongside ICICI Ventures IAF5, Amal Parikh and other marquee investors. UBS acted as exclusive advisor in this fundraise. This marks as one of the largest growth-stage investments in India’s lab-grown diamond sector.

The capital will be deployed to accelerate the company’s next phase of growth. Key priorities include scaling lab-grown diamond production, strengthening working capital and the rollout of a pan-India physical retail network. In parallel, the company shall advance its work in precision single-crystal diamonds for high-value applications across optical, quantum and thermal domains, addressing the evolving needs of the defence, semiconductor, and deep-tech sectors.

DLGD is the lab-grown diamond jewellery arm of the Hari Krishna Group, founded by Savji Dholakia, Ghanshyam Dholakia, Himmat Dholakia, and Tulsi Dholakia. With over 33 years of experience, the Group is one of India’s leading names in the diamond industry and is well-positioned to create greater impact while continuing to give back through the Dholakia Foundation. DLGD is also among the earliest global adopters of lab-grown diamonds, having introduced the category to major US retailers as early as 2018.

DLGD stands apart through a fully integrated supply chain: From growing diamonds, cutting and polishing, designing and manufacturing jewellery, and selling directly to retailers and brands worldwide.

Its proprietary technologies span diamond growing processes, robotic manufacturing, AI-assisted design, and an inventory-light configurator, enabling retailers to offer personalised, made-to-order pieces without holding large stock. All production is powered by renewable energy and uses recycled metal, reinforcing its sustainability commitments.

Speaking on the funding, Savji Dholakia, Founder, Hari Krishna Group, said: “This is a proud and fulfilling moment for me, especially after handing over leadership to the next generation eight years ago. Seeing them collaborate with like-minded investors is a strong validation of their vision to scale the platform with greater speed and ambition.”

Hasu Dholakiya, CEO of Dholakia Lab Grown Diamond, added: “This investment is a strong vote of confidence in our model and reflects the world’s growing confidence in lab-grown diamonds. Global retailers and luxury brands are increasing their lab-grown commitments, and we intend to be the manufacturing and design partner of choice. We built this business with discipline, and now we have the resources to scale it responsibly, innovatively, and transparently.

Ankit Aggarwal, Fund Manager, Private Equity, Abakkus Asset Manager Pvt. Ltd., said: “Consumer attitudes toward lab-grown diamonds have reached a tipping point, with younger buyers choosing them as a preference for quality, ethics, and value. DLGD is well-positioned at the centre of this shift, with the production capabilities and global retail relationships to capture it at scale, as demand for sustainable luxury continues to grow.”

Gagandeep S Chhina, representing ICICI Venture, stated: “Lab Grown Diamonds represent a structurally growing segment in the global jewellery industry and we are excited to partner with Hari Krishna group as the business scales both globally and in India. DLGD’s significant control on the value chain with in-house diamond manufacturing, expertise in design and jewellery making and deep relationships with customers globally provides DLGD a strong growth platform with significant focus on profitability.”

About Dholakia Lab Grown Diamond Private Limited (DLGD): DLGD is the lab-grown diamond jewellery arm of the Hari Krishna Group, a 33-year-old global diamond leader. The company is fully vertically integrated, with growing and cutting operations in Surat, jewellery manufacturing in Mumbai, and commercial operations in New Jersey, USA. DLGD serves 100+ retailers and brands across 25+ countries.

About Abakkus PE: Abakkus Four2Eight Opportunities Fund, is the maiden Private Equity fund of Abakkus Asset Manager Private Limited, a leading Asset Manager with an AUM of ~$4 billion, founded by Mr. Sunil Singhania. In line with their sector‑agnostic investment philosophy to back scalable businesses with strong founders, Abakkus PE has invested in several high-quality companies since the fund’s inception in 2024.

About ICICI Venture IAF5: ICICI Venture, a division of ICICI Prudential Asset Management Company Limited, is one of India’s oldest and most prominent Alternative Asset managers. ICICI Venture enjoys a distinctive track record of sector agnostic PE and VC investments in India, across 500+ deals across 11 funds, across a range of sectors such as Consumer Products and Services, Foods & QSR, Banking, Financial Services, Insurance, Lifesciences, Healthcare, Pharmaceuticals, Fine Chemicals, Media & Entertainment, Specialty Manufacturing, etc during the last 30+ years. IAF5 is the current Growth PE fund managed by ICICI Venture.

Media Contact

Company name: Dholakia Lab Grown Diamond Private Limited (DLGD)
Website: https://dholakia.co/jewellery
Email id: [email protected]

Disclaimer:  This content is provided by Dholakia Lab Grown Diamond Private Limited (DLGD). The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or business advice. All investments carry inherent risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or financial losses resulting from the use or reliance on the information in this press release. Speculate only with funds you can afford to lose. In the event of any legal claims or concerns regarding this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.

Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bc2ee7d4-bbab-4cf9-97cf-565fc2efa491

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Gabelli 18th Annual Sports & Media Symposium Agenda Released

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

Jackery Brings the Power and Savings to Memorial Day Weekend

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

PruittHealth Certified as a Great Place to Work for Fifth Consecutive Year

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

Editors Picks

BranchOut Food Shareholder Update: Record Production and Major Customer Deliveries Position Company for Record Q2

May 14, 2026

BitFuFu Announces April 2026 Bitcoin Production and Operational Updates

May 14, 2026

Jackery Brings the Power and Savings to Memorial Day Weekend

May 14, 2026

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

May 14, 2026

Latest News

EV, hybrid sales 75% higher than March 2025 as gas prices near records

May 14, 2026

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

May 14, 2026

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

May 14, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version